Research Analysts’ Weekly Ratings Changes for Merck KGaA (MRK)

Merck KGaA (FRA: MRK) recently received a number of ratings updates from brokerages and research firms:

  • 5/22/2019 – Merck KGaA had its “buy” rating reaffirmed by analysts at DZ Bank AG.
  • 5/22/2019 – Merck KGaA was given a new €108.00 ($125.58) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 5/17/2019 – Merck KGaA was given a new €96.00 ($111.63) price target on by analysts at Morgan Stanley. They now have a “neutral” rating on the stock.
  • 5/17/2019 – Merck KGaA was given a new €94.00 ($109.30) price target on by analysts at Nord/LB. They now have a “neutral” rating on the stock.
  • 5/16/2019 – Merck KGaA was given a new €96.00 ($111.63) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 5/15/2019 – Merck KGaA was given a new €110.00 ($127.91) price target on by analysts at Credit Suisse Group AG. They now have a “buy” rating on the stock.
  • 5/14/2019 – Merck KGaA was given a new €82.00 ($95.35) price target on by analysts at Barclays PLC. They now have a “sell” rating on the stock.
  • 5/14/2019 – Merck KGaA was given a new €108.00 ($125.58) price target on by analysts at Sanford C. Bernstein. They now have a “neutral” rating on the stock.
  • 5/14/2019 – Merck KGaA was given a new €103.00 ($119.77) price target on by analysts at Warburg Research. They now have a “neutral” rating on the stock.
  • 5/14/2019 – Merck KGaA was given a new €106.00 ($123.26) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 5/14/2019 – Merck KGaA was given a new €110.00 ($127.91) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 5/13/2019 – Merck KGaA was given a new €104.00 ($120.93) price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
  • 5/13/2019 – Merck KGaA was given a new €100.00 ($116.28) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock.
  • 5/9/2019 – Merck KGaA was given a new €97.00 ($112.79) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 5/7/2019 – Merck KGaA was given a new €100.00 ($116.28) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock.
  • 5/3/2019 – Merck KGaA was given a new €82.00 ($95.35) price target on by analysts at Barclays PLC. They now have a “sell” rating on the stock.
  • 4/25/2019 – Merck KGaA was given a new €104.00 ($120.93) price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
  • 4/16/2019 – Merck KGaA was given a new €103.00 ($119.77) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 4/16/2019 – Merck KGaA had its “neutral” rating reaffirmed by analysts at DZ Bank AG.
  • 4/15/2019 – Merck KGaA was given a new €108.00 ($125.58) price target on by analysts at Sanford C. Bernstein. They now have a “neutral” rating on the stock.
  • 4/12/2019 – Merck KGaA was given a new €100.00 ($116.28) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock.
  • 4/9/2019 – Merck KGaA was given a new €103.00 ($119.77) price target on by analysts at Warburg Research. They now have a “neutral” rating on the stock.
  • 4/9/2019 – Merck KGaA was given a new €108.00 ($125.58) price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
  • 4/8/2019 – Merck KGaA was given a new €82.00 ($95.35) price target on by analysts at Barclays PLC. They now have a “sell” rating on the stock.
  • 4/8/2019 – Merck KGaA was given a new €105.00 ($122.09) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 4/2/2019 – Merck KGaA had its “neutral” rating reaffirmed by analysts at DZ Bank AG.
  • 4/2/2019 – Merck KGaA was given a new €103.00 ($119.77) price target on by analysts at Warburg Research. They now have a “neutral” rating on the stock.
  • 4/1/2019 – Merck KGaA was given a new €108.00 ($125.58) price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
  • 4/1/2019 – Merck KGaA was given a new €110.00 ($127.91) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.

Shares of FRA MRK opened at €90.64 ($105.40) on Monday. Merck KGaA has a 12-month low of €76.60 ($89.07) and a 12-month high of €115.00 ($133.72).

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments.

Further Reading: Economic Reports

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.